Schwab International Equity ETF (SCHF) is an exchange-traded fund that seeks to track the total return of the FTSE Developed ex US Index (Net), a market capitalization-weighted index comprising large- and mid-cap stocks from developed markets outside the United States. The ETF provides passive exposure to approximately 1,499 holdings across diversified sectors including financials (25.13%), industrials (18.76%), information technology (10.17%), consumer discretionary (9.44%), and health care (8.98%); top holdings include ASML Holding NV (1.64%), Samsung Electronics Ltd (1.27%), Roche Holding Par AG (1.10%), AstraZeneca PLC (1.06%), and HSBC Holdings PLC (1.01%). It offers investors low-cost access (0.030% expense ratio) to equities domiciled primarily in Japan (21.28%), the United Kingdom (12.26%), Canada (10.76%), France (8.50%), and Germany (7.78%), targeting institutional and retail investors seeking international diversification within a core portfolio allocation. Launched on November 3, 2009, and issued by Charles Schwab Investment Management, Inc., a subsidiary of The Charles Schwab Corporation headquartered in Westlake, Texas, SCHF trades on NYSE Arca under the ticker SCHF with total net assets exceeding $54 billion as of December 2025. Recent developments include a 2-for-1 forward share split effective October 10, 2024, which increased shares outstanding and adjusted net asset value per share without altering shareholder value; a reduction in its operating expense ratio effectuated in June 2025 as part of Schwab Asset Management's initiative to bring all equity index ETF costs below 10 basis points; and semi-annual distributions, with the latest income payout of $0.6780 on December 16, 2025.